Encapsulated GDNF-producing C2C12 cells for Parkinson's disease: a pre-clinical study in chronic MPTP-treated baboons
暂无分享,去创建一个
J. Bloch | H. Kishima | F. Condé | S. Palfi | N. Déglon | P. Aebischer | J. Dauguet | F. Dollé | P. Hantraye | F. Hinnen | W. Pralong | T. Poyot
[1] P. Aebischer,et al. Gene therapy approaches for Parkinson's disease , 2003 .
[2] S. Konitsiotis,et al. Complications of a trophic xenotransplant approach in parkinsonian monkeys , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[3] D. Brooks,et al. Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease , 2003, Nature Medicine.
[4] Richard Grondin,et al. Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys. , 2002, Brain : a journal of neurology.
[5] I. Date,et al. Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF‐producing cells in a rat model of Parkinson's disease , 2002, Journal of neuroscience research.
[6] R. Bakay,et al. Lentivirally Delivered Glial Cell Line-Derived Neurotrophic Factor Increases the Number of Striatal Dopaminergic Neurons in Primate Models of Nigrostriatal Degeneration , 2002, The Journal of Neuroscience.
[7] Alexandre Mendes,et al. Treatment results: Parkinson's disease , 2002, Movement disorders : official journal of the Movement Disorder Society.
[8] H. Mizukami,et al. Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease , 2002, Gene Therapy.
[9] A. Björklund,et al. Neuroprotection in the rat Parkinson model by intrastriatal GDNF gene transfer using a lentiviral vector , 2002, Neuroreport.
[10] L Lopiano,et al. Deep brain stimulation of the subthalamic nucleus: anatomical, neurophysiological, and outcome correlations with the effects of stimulation , 2002, Journal of neurology, neurosurgery, and psychiatry.
[11] P. Aebischer,et al. Sustained delivery of GDNF: towards a treatment for Parkinson’s disease , 2001, Brain Research Reviews.
[12] J Q Trojanowski,et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. , 2001, The New England journal of medicine.
[13] J. Bloch,et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. , 2000, Science.
[14] P Aebischer,et al. Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF. , 2000, Human gene therapy.
[15] G. Donnan,et al. New dopaminergic neurons in Parkinson's disease striatum , 2000, The Lancet.
[16] P. Aebischer,et al. Evaluation of an Intrathecal Immune Response in Amyotrophic Lateral Sclerosis Patients Implanted with Encapsulated Genetically Engineered Xenogeneic Cells , 2000, Cell transplantation.
[17] J. Bloch,et al. Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's disease. , 2000, Human gene therapy.
[18] Krishna Kumar,et al. Deep Brain Stimulation of the Ventral Intermediate Nucleus of the Thalamus for Control of Tremors in Parkinson’s Disease and Essential Tremor , 2000, Stereotactic and Functional Neurosurgery.
[19] Timothy Sendera,et al. Clinicopathological findings following intraventricular glial‐derived neurotrophic factor treatment in a patient with Parkinson's disease , 1999, Annals of neurology.
[20] Karl J. Friston,et al. Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.
[21] A. Lang,et al. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease , 1998, Neurology.
[22] C. Crouzel,et al. 6‐[18F]Fluoro‐L‐DOPA by radiofluorodestannylation: a short and simple synthesis of a new labelling precursor , 1998 .
[23] C. Spenger,et al. Implants of Polymer-Encapsulated Genetically Modified Cells Releasing Glial Cell Line-Derived Neurotrophic Factor Improve Survival, Growth, and Function of Fetal Dopaminergic Grafts , 1998, Experimental Neurology.
[24] A. Björklund,et al. Studies on Neuroprotective and Regenerative Effects of GDNF in a Partial Lesion Model of Parkinson's Disease , 1997, Neurobiology of Disease.
[25] N. Déglon,et al. A gene therapy approach to regulated delivery of erythropoietin as a function of oxygen tension. , 1997, Human gene therapy.
[26] R. Turner,et al. Dopaminergic Neurons Intrinsic to the Primate Striatum , 1997, The Journal of Neuroscience.
[27] N. Déglon,et al. Central nervous system delivery of recombinant ciliary neurotrophic factor by polymer encapsulated differentiated C2C12 myoblasts. , 1996, Human gene therapy.
[28] Gunnar Brix,et al. Performance evaluation of the whole-body PET scanner ECAT EXACT HR/sup +/ , 1996, 1996 IEEE Nuclear Science Symposium. Conference Record.
[29] O. Andreassen,et al. Estimation of the number of somatostatin neurons in the striatum: An in situ hybridization study using the optical fractionator method , 1996, The Journal of comparative neurology.
[30] Myriam Schluep,et al. Intrathecal delivery of CNTF using encapsulated genetically modifiedxenogeneic cells in amyotrophic lateral sclerosis patients , 1996, Nature Medicine.
[31] B. Hoffer,et al. Functional recovery in parkinsonian monkeys treated with GDNF , 1996, Nature.
[32] D. Pipeleers,et al. Expression and Functional Activity of Glucagon, Glucagon-Like Peptide I, and Glucose-Dependent Insulinotropic Peptide Receptors in Rat Pancreatic Islet Cells , 1996, Diabetes.
[33] Vincent Frouin,et al. Clinical correlates of {18F}fluorodopa uptake in five grafted Parkinsonian patients , 1995, Annals of neurology.
[34] L. Olson,et al. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo , 1995, Nature.
[35] R. Vandlen,et al. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain , 1995, Nature.
[36] D. Riche,et al. Chronic MPTP treatment reproduces in baboons the differential vulnerability of mesencephalic dopaminergic neurons observed in parkinson's disease , 1994, Neuroscience.
[37] Y. Samson,et al. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. , 1994, Brain : a journal of neurology.
[38] G. Brownell,et al. Dopamine Terminal Loss and Onset of Motor Symptoms in MPTP-Treated Monkeys: A Positron Emission Tomography Study with 11C-CFT , 1994, Experimental Neurology.
[39] J. Lile,et al. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. , 1993, Science.
[40] D. Riche,et al. Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons , 1993, Neuroscience.
[41] N Satyamurthy,et al. Regioselective radiofluorodestannylation with [18F]F2 and [18F]CH3COOF: a high yield synthesis of 6-[18F]Fluoro-L-dopa. , 1992, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.
[42] H. Gundersen,et al. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator , 1991, The Anatomical record.
[43] C D Marsden,et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. , 1990, Science.
[44] Richard F. Martin,et al. Primate neostriatal neurons containing tyrosine hydroxylase: Immunohistochemical evidence , 1987, Neuroscience Letters.
[45] C. Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[46] S. Hsu,et al. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[47] Banknieder Ar,et al. Comparison of ketmine with the combination of ketamine and xylazine for effective anesthesia in the rhesus monkey (Macaca mulatta). , 1978 .
[48] P. Aebischer,et al. Encapsulated neural transplants. , 2000, Progress in brain research.
[49] Karl J. Friston,et al. Spatial registration and normalization of images , 1995 .
[50] Karl J. Friston,et al. Statistical parametric maps in functional imaging: A general linear approach , 1994 .
[51] Karl J. Friston,et al. Comparing Functional (PET) Images: The Assessment of Significant Change , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.